ZIRANU, PINA
 Distribuzione geografica
Continente #
EU - Europa 33.280
NA - Nord America 1.971
AS - Asia 1.401
SA - Sud America 229
AF - Africa 44
Totale 36.925
Nazione #
IT - Italia 32.694
US - Stati Uniti d'America 1.908
SG - Singapore 624
CN - Cina 340
VN - Vietnam 178
BR - Brasile 173
SE - Svezia 149
DE - Germania 88
FR - Francia 72
GB - Regno Unito 69
IN - India 57
HK - Hong Kong 50
FI - Finlandia 48
NL - Olanda 33
CA - Canada 31
MX - Messico 23
ES - Italia 20
IE - Irlanda 20
IQ - Iraq 20
BD - Bangladesh 16
PL - Polonia 16
KR - Corea 15
AT - Austria 14
EC - Ecuador 14
TR - Turchia 14
UA - Ucraina 14
CO - Colombia 13
ZA - Sudafrica 13
JP - Giappone 12
AR - Argentina 11
MA - Marocco 10
PK - Pakistan 10
BE - Belgio 9
ID - Indonesia 8
RU - Federazione Russa 8
VE - Venezuela 7
IR - Iran 6
PH - Filippine 6
IL - Israele 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
KE - Kenya 4
KG - Kirghizistan 4
LT - Lituania 4
PE - Perù 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
BZ - Belize 3
CZ - Repubblica Ceca 3
KZ - Kazakistan 3
MK - Macedonia 3
PY - Paraguay 3
TN - Tunisia 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
LU - Lussemburgo 2
MU - Mauritius 2
MY - Malesia 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
Totale 36.925
Città #
Cagliari 31.278
Uta 1.181
Singapore 371
Ashburn 295
Dallas 233
San Jose 169
Fairfield 100
Boardman 93
Beijing 83
Nyköping 83
Chandler 78
Los Angeles 70
New York 58
Ho Chi Minh City 56
Houston 53
Seattle 51
Hong Kong 47
Wilmington 42
The Dalles 41
Woodbridge 40
Santa Clara 37
Hanoi 34
Helsinki 34
Cambridge 31
Rome 29
Orem 27
Amsterdam 24
Frankfurt am Main 24
Boston 23
Shanghai 23
Lauterbourg 21
Hefei 20
London 19
Buffalo 17
Chicago 17
Nuremberg 17
Redondo Beach 17
Dearborn 16
Guangzhou 16
Munich 15
Seoul 15
São Paulo 15
Dublin 14
Toronto 13
Warsaw 13
Dong Ket 12
Montreal 12
Pune 12
Chennai 11
Düsseldorf 11
Poplar 11
Ann Arbor 10
Jacksonville 10
Milan 10
Brooklyn 9
New Delhi 9
Paris 9
San Diego 9
Baghdad 8
Denver 8
Johannesburg 8
Lappeenranta 8
Mexico City 8
Rio de Janeiro 8
Stockholm 8
Tokyo 8
Da Nang 7
Haiphong 7
Manchester 7
Quito 7
Selargius 7
Turin 7
Belo Horizonte 6
Casablanca 6
Council Bluffs 6
Lahore 6
Nanjing 6
Phoenix 6
Salt Lake City 6
Shenzhen 6
Wuhan 6
Bexley 5
Biên Hòa 5
Boulder 5
Brussels 5
Centro 5
Guayaquil 5
Hangzhou 5
Hải Dương 5
Medellín 5
Menlo Park 5
Naples 5
Olbia 5
Turku 5
Vienna 5
Zhengzhou 5
Atlanta 4
Augusta 4
Bishkek 4
Campinas 4
Totale 35.339
Nome #
Clustered protocadherins methylation alterations in cancer 3.318
BRAF-mutant colorectal cancer, a different breed evolving 3.242
Molecular-biology-driven treatment for metastatic colorectal cancer 2.771
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples 2.687
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.364
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab 2.140
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.124
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study 1.859
Immunotherapy and Cancer: The Multi-Omics Perspective 1.609
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.539
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.222
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue 1.043
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 987
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 959
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer 934
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 786
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 775
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 741
Uncovering key targets of success for immunotherapy in pancreatic cancer 720
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 646
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 596
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 506
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 435
CD44: A New Prognostic Marker in Colorectal Cancer? 272
A new prognostic score for biliary tract cancer: a multicenter experience 218
REINVENT (REgorafenIb traNslational eValuation angiogENesis proTocol) 217
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 210
Early taxane exposure and neurotoxicity in breast cancer patients 203
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 199
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 192
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 183
Medical management of malignant bowel obstruction: our center experience 173
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 170
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 117
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 106
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 103
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study 103
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 102
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 100
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 100
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 94
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 93
The role of metastasectomy in patients with early onset metastatic colorectal cancer 91
Totale 37.049
Categoria #
all - tutte 50.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.046 0 0 0 0 0 0 0 0 0 426 385 235
2021/20222.350 196 120 63 131 142 126 101 128 218 252 312 561
2022/20233.974 319 654 564 307 286 357 175 306 275 290 290 151
2023/20245.431 233 115 136 192 296 560 565 2.165 169 229 374 397
2024/202510.559 3.026 3.284 1.030 1.034 484 701 448 51 122 109 76 194
2025/20263.696 329 255 372 376 300 298 796 387 235 348 0 0
Totale 37.049